RemeGen Rises, Falls Along With Chinese Antibody Ambitions

Discipline, Deals Key?

 
• By Brian Yang
  
Share price falling
RemeGen's stock price hit in apparent reflection of multiple challenges • Source: Shutterstock

More from China

More from Focus On Asia